A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies
Clinical trial NCT05338346 · TERMINATED
Trial details
- NCT number
- NCT05338346
- Sponsor
- Antengene Discovery Limited
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-08
- Primary completion
- 2024-01-08
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.